CDD-2789 is a potent (IC50 = 3.9 nM ALK1, 2.1 nM ALK2) and selective ALK1/2 inhibitor. It attenuated activin A and BMP-induced phosphorylated SMAD1/5 activation in fibroblasts in a dose-dependent manner.
* VAT and and shipping costs not included. Errors and price changes excepted